MUMBAI: Strides Arcolab has informed the stock exchange that the company and Abdi Ibrahim, Turkey's largest pharmaceutical company, has signed a 50:50 joint venture agreement to introduce a range of specialty pharmaceutical products developed by the company for the Turkish and neighbouring markets. The new company will be called Abdi Strides and will leverage the product pipeline and manufacturing capabilities of the company and the sales and marketing leadership of Abdi Ibrahim in Turkey.